Cargando…
Non-Apoptotic Programmed Cell Death in Thyroid Diseases
Thyroid disorders are among the most common endocrinological conditions. As the prevalence of thyroid diseases increases annually, the exploration of thyroid disease mechanisms and the development of treatments are also gradually improving. With the gradual advancement of therapies, non-apoptotic pr...
Autores principales: | Ji, Feihong, Qiu, Xinguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788139/ https://www.ncbi.nlm.nih.gov/pubmed/36559016 http://dx.doi.org/10.3390/ph15121565 |
Ejemplares similares
-
Systematic analysis of the prognosis and immune infiltration of E2Fs in thyroid carcinoma
por: Fu, Xinghao, et al.
Publicado: (2023) -
“Micro” Extrathyroidal Extension in Risk Stratification for Papillary Thyroid Carcinoma: Should It Be in the Intermediate-Risk or High-Risk Group? A Single-Center Retrospective Study
por: He, Qi, et al.
Publicado: (2022) -
Emerging roles for lipids in non-apoptotic cell death
por: Magtanong, L, et al.
Publicado: (2016) -
Non-Apoptotic Cell Death Signaling Pathways in Melanoma
por: Hartman, Mariusz L.
Publicado: (2020) -
Flipping the dogma – phosphatidylserine in non-apoptotic cell death
por: Shlomovitz, Inbar, et al.
Publicado: (2019)